Saakshi Medtech & Panels Share Price Today | Stock Price & Saakshi Medtech & Panels Share Screener
Track the current Saakshi Medtech & Panels share price and stock price live with TickJournal's free stock screener. Check SAAKSHI 52-week performance for the annual price range and momentum. Use the Saakshi Medtech & Panels stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Saakshi Medtech & Panels opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Saakshi Medtech & Panels Share Price Chart
Track the current stock price of Saakshi Medtech & Panels with an interactive chart. Analyse SAAKSHI share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Saakshi Medtech & Panels stock quote in one place.
Saakshi Medtech & Panels Company Profile - Fundamental Screener
Screen Saakshi Medtech & Panels company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SAAKSHI shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Capital Goods sector and the Other Electrical Equipment industry, and it trades under ISIN INE0PSK01027.
Company Details
Classification
Identifiers and Leadership
Saakshi Medtech & Panels Balance Sheet Screener
Screen SAAKSHI balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹157, up from ₹131 in 2025.
Latest statistics put total assets at ₹157 and shareholder funds at ₹110, with a leverage ratio of 0.19.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
Assets |
||||||||
| Total Assets | 157 | 131 | 131 | 93 | 65 | 56 | 48 | 39 |
| Current Assets | 61 | 54 | 66 | 56 | 37 | 31 | 23 | 21 |
| Fixed Assets | 93 | 60 | 62 | 34 | 26 | 22 | 23 | 15 |
Liabilities |
||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 17 | 15 | 17 | 10 | 8 | 9 | 9 | 6 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
||||||||
| Total Equity | 110 | 98 | 93 | 42 | 30 | 20 | 18 | 12 |
| Share Capital | 18 | 18 | 18 | 3 | 3 | 3 | 3 | 3 |
| Reserves & Surplus | 93 | 80 | 76 | 40 | 27 | 18 | 15 | 9 |
Saakshi Medtech & Panels Income Statement Screener - Profit & Revenue Analysis
Screen Saakshi Medtech & Panels income statement and profit fundamentals. Analyze SAAKSHI quarterly results. Saakshi Medtech & Panels reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For None-None, revenue was ₹0 and net profit was ₹0.
In that period expenses were ₹0, interest cost ₹0 and tax ₹0. The next period listed, 2025-March, shows revenue of ₹93 and net profit of ₹5.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March |
|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | ||||||||
| Revenue | 0 | 93 | 123 | 122 | 92 | 60 | 62 | 38 |
| Expenses | 0 | 82 | 102 | 102 | 76 | 54 | 50 | 34 |
Operating Costs and Margins | ||||||||
| EBITDA | 0 | 11 | 20 | 21 | 16 | 6 | 12 | 4 |
| Operating Profit % | 0.00% | 11.00% | 16.00% | 17.00% | 17.00% | 10.00% | 18.00% | 10.00% |
| Depreciation | 0 | 4 | 4 | 3 | 2 | 2 | 2 | 1 |
| Interest | 0 | 0 | 2 | 2 | 1 | 2 | 2 | 1 |
Profit and Earnings | ||||||||
| Profit Before Tax | 0 | 7 | 15 | 17 | 13 | 3 | 8 | 2 |
| Tax | 0 | 2 | 4 | 4 | 3 | 1 | 2 | 1 |
| Net Profit | 0 | 5 | 11 | 12 | 9 | 2 | 6 | 2 |
| EPS | 0.00 | 2.67 | 6.40 | 9.52 | 7.21 | 80.96 | 222.60 | 61.88 |
Saakshi Medtech & Panels Cash Flow Screener - Liquidity Fundamentals
Screen SAAKSHI cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2025-March, operating activities generated ₹3, and net cash flow was an outflow of ₹12.
Over the same period, investing activities used ₹15 and financing activities used ₹1.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March |
|---|---|---|---|---|---|---|---|
Cash from Operations and Investing | |||||||
| Operating Activities | 3 | 8 | 11 | 11 | 0 | 11 | 0 |
| Investing Activities | -15 | -31 | -11 | -6 | -1 | -7 | -9 |
Financing and Net Cash | |||||||
| Financing Activities | -1 | 36 | 2 | -7 | 2 | -3 | 8 |
| Net Cash Flow | -12 | 12 | 2 | -2 | 1 | 2 | -1 |
Saakshi Medtech & Panels Shareholding Pattern Screener
See Saakshi Medtech & Panels shareholding pattern with promoter, FII, and DII holdings. Check Saakshi Medtech & Panels promoter holding and ownership changes for SAAKSHI on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Mar, promoters held 74.82%, foreign institutions 0.07%, domestic institutions 0.30% and the public 21.17%, spread across 1,642 shareholders.
The shareholder count was 1,642 in 2026-Mar, compared with 1,409 in 2026-Jun.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Sept | 2024-Mar | 2024-Sept | 2024-Dec | 2023-Sept |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 74.82% | 74.82% | 73.63% | 73.89% | 73.63% | 73.63% | 73.63% | 73.63% |
Institutional Investors | ||||||||
| FII Holding | 0.07% | 0.07% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.30% | 0.27% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.07% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 21.17% | 21.30% | 22.37% | 20.77% | 22.07% | 22.60% | 22.64% | 11.18% |
| Other Holding | 3.64% | 3.54% | 4.00% | 5.33% | 4.30% | 3.77% | 3.73% | 15.12% |
| Shareholder Count | 1,642 | 1,409 | 1,914 | 1,913 | 1,389 | 1,780 | 1,985 | 1,705 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Saakshi Medtech & Panels. Saakshi Medtech & Panels dividend yield can be compared with peers and other stocks in the market.
Saakshi Medtech & Panels Stock Index Membership - Nifty & Sensex
See which indices include Saakshi Medtech & Panels stock. Check SAAKSHI index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Saakshi Medtech & Panels Market Events Screener - Corporate Actions
Get Saakshi Medtech & Panels corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Saakshi Medtech & Panels stock events that may affect SAAKSHI share price, along with derivatives, futures and options activity and sector gainers.
6 corporate actions are listed, the most recent entry being Extraordinary General Meeting dated June 2, 2026, with a record date of June 2, 2026.
It is followed by Quarterly Result Announcement dated May 26, 2026 and Quarterly Result Announcement dated November 14, 2025.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-06-02 | 2026-06-02 | Extraordinary General Meeting | NA | -8.17% |
| 2026-05-26 | 2026-05-26 | Quarterly Result Announcement | NA | -1.90% |
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | -3.35% |
| 2025-05-28 | 2025-05-28 | Quarterly Result Announcement | NA | 1.00% |
| 2024-11-13 | 2024-11-13 | Quarterly Result Announcement | NA | 0.23% |
| 2024-09-30 | 2024-09-30 | Annual General Meeting | NA | -9.44% |
Saakshi Medtech & Panels Competitors Screener - Peer Stocks Comparison
Screen SAAKSHI competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Capital Goods sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Apar Industries | 73,369 | 63.14 | 22,967 | 22.95% | 977 | 53.62 |
| Waaree Energies | 68,274 | 17.21 | 27,245 | 83.52% | 3,884 | 30.92 |
| Premier Energies | 39,762 | 23.70 | 8,026 | 20.65% | 1,510 | 30.95 |
| Emmvee Photovoltaic Power | 21,996 | 17.08 | 5,103 | 116.22% | 1,082 | 41.99 |
| Avalon Technologies | 15,401 | 115.40 | 1,632 | 46.35% | 113 | 52.67 |
| Genus Power Infrastructures | 8,858 | 13.77 | 4,821 | 90.97% | 565 | 32.68 |
| Vikram Solar | 5,801 | 16.24 | 4,862 | 40.86% | 469 | 37.75 |
| Ram Ratna Wires | 5,454 | 42.66 | 5,195 | 40.61% | 109 | 64.27 |
| Saatvik Green Energy | 5,260 | 21.44 | 4,548 | 107.45% | 350 | 46.25 |
| Shilchar Technologies | 4,672 | 33.55 | 678 | 6.00% | 158 | 46.47 |
Saakshi Medtech & Panels Company Announcements - News & Reports Screener
Screen SAAKSHI latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
Frequently Asked Questions
How is the company valued right now?
Market capitalisation stands at ₹717.82 Cr. The company operates in the Capital Goods sector, in the Other Electrical Equipment industry, so compare these ratios with its sector peers in the table above.
About This Data
Key statistics were last updated on October 5, 2026. This page covers 8 balance sheet periods, 8 income statement periods, 7 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.